基本信息
浏览量:4
职业迁徙
个人简介
Yasemin Yozgat (YY), is a dedicated scientist with 20 years of experience in cancer research and pharmaceutical applications. YY obtained a post-baccalaureate degree in Pre-medicine from Hunter College (CUNY). YY attained a graduate master's program from Columbia University and Ph.D. from Sabancı University while working full-time as a cancer researcher. YY has worked with top researchers from Columbia University and NYU for 2 years and at Memorial Sloan Kettering Cancer Center for 10 years, specializing in c-KIT RTK signaling and therapeutic intervention via pharmaceuticals (AKT, PI3K, mTOR, c-KIT inhibitors, etc.) under the supervision of Professor Peter Besmer. YY published in prestigious journals. Two of the Proceedings of the National Academy of Sciences (PNAS), Stem Cells, Molecular Cancer Research, and one is currently submitted at Nucleic Acids Research. YY is also in the process of submitting another paper rat Nature Medicine.
YY is currently working at Istanbul Medipol University as a permanent medical cancer researcher. YY focused on understanding the mechanisms of pathogenesis and developing biomarkers and targeted therapies based on insight into disease pathogenesis. Using multimodality approaches. YY is investigating the signaling pathways that drive the growth of cancer cells, with an eye toward designing new treatment options for patients with NSC lung, breast, ovarian, prostate cancer, and glioblastoma.
One of the main YY projects is cancer metabolism mechanisms that are responsible for Non-small cell lung (NSCL), breast, ovarian, and prostate cancer development and growth. YY has identified for the first time the existence of novel isoforms of hexokinase 1 -HK1b- as a predominant isoform of hexokinase 1 in NSCL, breast, ovarian cancer, and glioblastoma.
The second project YY has been working on deals with tumor heterogeneity and Cancer Stem Cell (CSCs) evolution and differentiation in different breast cancer subtype models. Importantly, how different sub-population of CSCs contribute to tumor development, and drug resistance within the same type of breast cancer and how we can use this knowledge to better target cancer cells is another focus.
In addition to these projects, YY collaborated with Dr. Murat Alper Cevher from Bilkent University focusing on biochemical/architectural as well as cell-based characterization of human transcription factors focusing especially on the most critical human Mediator co-activator complex,
YY has experience in primary and secondary cell culture, isolating cancer stem cells, CSCs culture, PDX animal model, and CRISPR Cas 9 technology for designing and constructing. YY has technical skills in molecular and cellular biology and biochemistry. A listing of all her skills and detailed experience can be found in her full CV
研究兴趣
论文共 11 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yasemin Baris, Javaid Jabbar,Yasemin Yozgat, Ege Cigirgan,Sadik Bay, Merve Erden Tucer,Volkan Aslan, Melike Dinccelik-Aslan,Murat Alper Cevher
biorxiv(2022)
Yasemin Yozgat,Emre Karakoç,Özgür Şahin,Şeyma ÇİMEN,Wael M. Rabeh,Mehmet Aydın,Adil Mardinoğlu,İhsan Gürsel,Aslı Çakır,Özge Şensoy,Ekrem Musa Özdemir, Yusuf Bayrak,Mehmet Zeki Günlüoğlu,Özge Saatçi, Javaid Jabbar,Juliana C. Ferreira, Melike Dinccelik Aslan,Muzaffer Yıldırım,Samman Mansoor,Bilal E. Kerman, Zeynep Aladağ,Woonghee Kim,Muhammad Arif,Emre Vatandaşlar,Olgu Enis Tok,Zeynep Doğru, Aslı Güner Öztürk Demir,Tugce Canavar Yildirim,Ihsan Yozgat,Şerif Şentürk,Gürkan Öztürk,Murat Cevher
bioRxiv (Cold Spring Harbor Laboratory) (2022)
mag(2011)
引用24浏览0引用
24
0
Ferdin Filipp,Yasemin Yozgat,Elisa de Stanchina,Darren Veach,Bayard Clarkson,Katia Manova, o G. Giancotti,Cristina R. Antonescu,Peter Besmer
semanticscholar(2010)
引用0浏览0引用
0
0
加载更多
作者统计
#Papers: 11
#Citation: 290
H-Index: 6
G-Index: 7
Sociability: 4
Diversity: 2
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn